El-Nakkady Sally S, Roaiah Hanaa F, El-Serwy Weam S, Soliman Abdel Mohsen, El-Moez Sherein I Abd, Abdel-Rahman Adel A H
Natural Products Department, National Research Center, Dokki, Cairo, Egypt.
Acta Pol Pharm. 2012 Jul-Aug;69(4):645-55.
Bromination of visnaginone (1) yielded the dibromo derivative (2), which upon methylation with methyl iodide gave 1-(2,7-dibromo-4,6-dimethoxybenzofuran-5-yl) ethanone (3). Compound (3) reacted with dimethylformamide dimethylacetal to give (4). The reaction of (3) with aromatic aldehydes namely (vanillin, benzaldehyde and 3-anisaldehyde) in ammonium acetate, malononitrile and/or butyric cyanoanhydride gave the 2-amino substituted nicotinonitriles (5a-c) and the 2-hydroxyl substituted nicotinonitriles (7a-c), respectively, while in piperidine gave (E)-1-(2,7-dibromo-4,6-dimethoxybenzofuran-5-yl)-3-(substituted)prop-2-en-l-one (11a-c). (5a) was hydrolyzed with sulfuric acid on cold to give the nicotinic acid derivative (6a). When compound (3) reacted with hydrazines and aromatic amines, it gave the Schiff bases (8a,b) and (10a,b), respectively. (8b) reacted with thioglycolic acid to give the thiazolidin-4-one (9b). When (11a-c) reacted with thiourea, it gave the pyrimidine derivatives (12a-c). (11a,b) also reacted with butyric cyanoanhydride and hydroxylamine hydrochloride to give (13a,b) and (15a,b), respectively. When the carboxylate (13a) was treated with 2,4-dinitroaniline, it gave the carboxamide (14a). Compounds (11b,c) reacted with hydrazine derivatives (hydrazine hydrate and phenylhydrazine) yielding the substituted pyrazole derivatives (16b,c) and (17b,c), respectively. All the structures of the synthesized compounds were elucidated by elemental analyses and spectral data. The newly synthesized benzofuran compounds showed a strong to moderate cytotoxicity against liver HEPG2 cancer cell line compared to 5-fluorouracil and doxorubicin (the anticancer agents). Compounds (2, 6a, 13a, 14a, 16c and 17b) were the most active compounds in descending order. The synthesized compounds were also tested for their antimicrobial activity. Compound (10b) showed the highest activity against all the tested strains followed by 6, 10a, 5a, 8b and 7a in descending order.
紫铆因酮(1)经溴化反应生成二溴衍生物(2),(2)再用碘甲烷进行甲基化反应得到1 -(2,7 - 二溴 - 4,6 - 二甲氧基苯并呋喃 - 5 - 基)乙酮(3)。化合物(3)与二甲基甲酰胺二甲基缩醛反应生成(4)。(3)与芳香醛(即香草醛、苯甲醛和3 - 茴香醛)在醋酸铵、丙二腈和/或丁腈酐存在下反应,分别生成2 - 氨基取代的烟腈(5a - c)和2 - 羟基取代的烟腈(7a - c),而在哌啶存在下反应生成(E)-1 -(2,7 - 二溴 - 4,6 - 二甲氧基苯并呋喃 - 5 - 基)-3 -(取代)丙 - 2 - 烯 - 1 - 酮(11a - c)。(5a)用硫酸在低温下水解得到烟酸衍生物(6a)。当化合物(3)与肼类和芳香胺反应时,分别生成席夫碱(8a,b)和(10a,b)。(8b)与巯基乙酸反应生成噻唑烷 - 4 - 酮(9b)。当(11a - c)与硫脲反应时,生成嘧啶衍生物(12a - c)。(11a,b)还与丁腈酐和盐酸羟胺反应,分别生成(13a,b)和(15a,b)。当羧酸盐(13a)用2,4 - 二硝基苯胺处理时,生成羧酰胺(14a)。化合物(11b,c)与肼衍生物(水合肼和苯肼)反应,分别生成取代的吡唑衍生物(16b,c)和(17b,c)。所有合成化合物的结构均通过元素分析和光谱数据得以阐明。与5 - 氟尿嘧啶和阿霉素(抗癌剂)相比,新合成的苯并呋喃化合物对肝癌HEPG2细胞系表现出强至中等程度的细胞毒性。化合物(2、6a、13a、14a、16c和17b)是活性最高的化合物,活性依次递减。还对合成化合物的抗菌活性进行了测试。化合物(10b)对所有测试菌株表现出最高活性,其次是6、10a、5a、8b和7a,活性依次递减。